Robert Goeltz
Director of Finance/CFO presso ARCUS BIOSCIENCES, INC.
Patrimonio netto: 291 809 $ in data 31/03/2024
Posizioni attive di Robert Goeltz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director of Finance/CFO | 01/08/2020 | - |
| Comptroller/Controller/Auditor | 01/08/2020 | 09/03/2023 |
Storia della carriera di Robert Goeltz
Precedenti posizioni note di Robert Goeltz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Director of Finance/CFO | 01/09/2017 | 01/08/2020 |
| CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 27/05/2015 | 15/05/2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director of Finance/CFO | 01/10/2013 | 01/05/2015 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 01/07/2002 | 01/08/2004 |
Formazione di Robert Goeltz
| Goizueta Business School-Emory | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Director of Finance/CFO | 5 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Borsa valori
- Insiders
- Robert Goeltz
- Esperienza
